Log in to save to my catalogue

Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the F...

Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the F...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_db9021625e4e4f6f8d1cd01395b7273e

Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression

About this item

Full title

Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression

Publisher

London, England: SAGE Publications

Journal title

Innate immunity (London, England), 2021-05, Vol.27 (4), p.294-312

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

In China, baicalin is the main active component of Scutellaria baicalensis, which has been used in the treatment of inflammation-related diseases, such as inflammation-induced acute lung injury. However, its specific mechanism remains unclear. This study examined the protective effect of baicalin on LPS-induced inflammation injury of alveolar epith...

Alternative Titles

Full title

Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_db9021625e4e4f6f8d1cd01395b7273e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_db9021625e4e4f6f8d1cd01395b7273e

Other Identifiers

ISSN

1753-4259

E-ISSN

1753-4267

DOI

10.1177/17534259211013887

How to access this item